TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TrialScope Leader to Speak at Clinical Trial Transparency Event in Europe


June 6, 2019

TrialScope Executive Selected to Speak at the 8th Annual
CBI Publication and  Clinical Trial Transparency Europe Event

Chief strategy officer to address the most recent trends and innovations
in clinical trial  data sharing and transparency

Jersey City, NJ – JUNE 6, 2019 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that Chief Strategy Officer  Thomas Wicks will deliver a presentation titled “Explore Recent Trends and Innovations in Data Sharing and Transparency” at CBI’s 8th Annual Publication and Clinical Trial Transparency Conference in Amsterdam.

The conference, which runs June 11-12, connects leading experts with the latest updates on global guidelines for clinical data sharing, best practices for collaborating with patients and benchmarking on innovative approaches to publishing.

“The clinical trial data disclosure requirements are evolving quite rapidly, making it imperative for the industry players to stay as up to date as possible on regulatory changes,” said Wicks. “I am honored to share my expertise on the topic of data sharing and transparency among representatives from pharma and life science organizations of all sizes. Sponsors attending this event and my presentation will demonstrate to the industry – and the public – that both legal and ethical transparency are a priority for their organization.”

Explore Recent Trends and Innovations in Data Sharing and Transparency

June 11 at 10 a.m. CEST

During his presentation, Wicks will explain why integrating every element of the data transparency lifecycle is critical to coordinating the public availability of clinical data, which includes disclosure, publications and data sharing. From his discussion, sponsors will walk away understanding of the importance of:

  • Establishing visibility and control across all channels through which clinical data are made available
  • Integrating the patient’s perspective in their own transparency efforts
  • Harmonizing the publication and disclosure calendars and content
  • Anticipating data sharing initiatives and planning for redaction and anonymization processes

For more information on CBI’s 8th Annual Publication and Clinical Trial Transparency Conference, and the full agenda, visit:

About TrialScope 

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit